Illness Related Distress in Women With Clinically Localized Cutaneous Melanoma

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

118 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-08-31

Study Completion Date

2013-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to examine the experiences and quality of life of women who have been treated for melanoma. By quality of life, we mean how they are feeling about different aspects of their life. In this study, we are especially interested in their feelings about survival, physical appearance and any family concerns. We will administer a series of QOL questionnaires, data sheets with many questions, to get their response to measure their feelings about these issues.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Health Behaviors, Surveillance, Psychosocial Factors, and Family Concerns

NCT00518050

Melanoma Survivors Psychological Factors

COMPLETED

Melanoma Risk-Reduction Among Patients and Family Members

NCT00510302

Melanoma

COMPLETED

Quality of Life in Patients With Nonmelanoma Skin Cancer

NCT00518037

Nonmelanoma Skin Cancer

COMPLETED

Holistic Needs Assessments in Patients With Melanoma

NCT06189261

Melanoma Unsatisfied Needs

COMPLETED

Quality of Life and Surgical Late Effects of Melanoma Treatment

NCT02352623

Melanoma Quality of Life Lymphedema +4 more

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Melanoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

female patients undergoing surgical treatment of cutaneous melanoma within two years of diagnosis and treatment

questionnaire on-line or if uncomfortable with a computer interface, paper copies will be provided

Intervention Type BEHAVIORAL

This pilot study will measure illness related distress in female patients undergoing surgical treatment of cutaneous melanoma within two years of diagnosis and treatment. Areas of particular focus will be survival anxiety, family functioning/childbearing concerns, and aesthetic impact of surgery. Patients will complete a one time only set of quality of life assessments these questionnaires will take 30-45 minutes to complete.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

questionnaire on-line or if uncomfortable with a computer interface, paper copies will be provided

This pilot study will measure illness related distress in female patients undergoing surgical treatment of cutaneous melanoma within two years of diagnosis and treatment. Areas of particular focus will be survival anxiety, family functioning/childbearing concerns, and aesthetic impact of surgery. Patients will complete a one time only set of quality of life assessments these questionnaires will take 30-45 minutes to complete.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18 years or older
* Clinically node-negative primary cutaneous melanoma.
* Patients participating must be female
* Patients must have completed surgical treatment for melanoma at least 10 days ago and less than 2 years at the time of study entry.